Current and historical daily PE Ratio for Neuren Pharmaceuticals Ltd (
ASX:NEU
) from 2005 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Neuren Pharmaceuticals stock (ASX:NEU) PE ratio as of Jun 05 2024 is 16.11.
More Details
Neuren Pharmaceuticals Ltd (ASX:NEU) PE Ratio (TTM) Chart
Neuren Pharmaceuticals Ltd (ASX:NEU) PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Total 1284
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Neuren Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 16.1 | 2024-04-04 | 17.3 |
| 2024-06-05 | 16.1 | 2024-04-03 | 17.0 |
| 2024-06-04 | 15.8 | 2024-04-02 | 17.9 |
| 2024-06-03 | 16.9 | 2024-04-01 | 17.7 |
| 2024-05-31 | 18.0 | 2024-03-29 | 17.7 |
| 2024-05-30 | 17.3 | 2024-03-28 | 17.7 |
| 2024-05-29 | 17.4 | 2024-03-27 | 17.3 |
| 2024-05-28 | 19.2 | 2024-03-26 | 16.9 |
| 2024-05-27 | 20.0 | 2024-03-25 | 17.1 |
| 2024-05-24 | 17.2 | 2024-03-22 | 16.8 |
| 2024-05-23 | 17.2 | 2024-03-21 | 17.3 |
| 2024-05-22 | 17.2 | 2024-03-20 | 17.2 |
| 2024-05-21 | 17.3 | 2024-03-19 | 17.1 |
| 2024-05-20 | 17.5 | 2024-03-18 | 17.1 |
| 2024-05-17 | 17.6 | 2024-03-15 | 16.9 |
| 2024-05-16 | 18.1 | 2024-03-14 | 16.4 |
| 2024-05-15 | 17.8 | 2024-03-13 | 17.2 |
| 2024-05-14 | 16.8 | 2024-03-12 | 17.6 |
| 2024-05-13 | 15.9 | 2024-03-11 | 16.7 |
| 2024-05-10 | 15.9 | 2024-03-08 | 16.6 |
| 2024-05-09 | 16.1 | 2024-03-07 | 16.2 |
| 2024-05-08 | 16.7 | 2024-03-06 | 16.4 |
| 2024-05-07 | 16.9 | 2024-03-05 | 16.4 |
| 2024-05-06 | 16.5 | 2024-03-04 | 16.4 |
| 2024-05-03 | 16.4 | 2024-03-01 | 16.4 |
| 2024-05-02 | 16.0 | 2024-02-29 | 16.1 |
| 2024-05-01 | 15.9 | 2024-02-28 | 15.9 |
| 2024-04-30 | 16.0 | 2024-02-27 | 17.9 |
| 2024-04-29 | 16.0 | 2024-02-26 | 18.2 |
| 2024-04-26 | 15.5 | 2024-02-23 | 17.3 |
| 2024-04-25 | 15.7 | 2024-02-22 | 16.8 |
| 2024-04-24 | 15.7 | 2024-02-21 | 16.8 |
| 2024-04-23 | 16.1 | 2024-02-20 | 17.1 |
| 2024-04-22 | 16.1 | 2024-02-19 | 17.3 |
| 2024-04-19 | 15.8 | 2024-02-16 | 16.5 |
| 2024-04-18 | 16.4 | 2024-02-15 | 19.2 |
| 2024-04-17 | 16.2 | 2024-02-14 | 19.1 |
| 2024-04-16 | 16.2 | 2024-02-13 | 19.1 |
| 2024-04-15 | 17.0 | 2024-02-12 | 18.9 |
| 2024-04-12 | 17.3 | 2024-02-09 | 18.8 |
| 2024-04-11 | 17.3 | 2024-02-08 | 18.7 |
| 2024-04-10 | 17.4 | 2024-02-07 | 19.1 |
| 2024-04-09 | 17.1 | 2024-02-06 | 19.0 |
| 2024-04-08 | 17.3 | 2024-02-05 | 18.8 |
| 2024-04-05 | 17.3 | 2024-02-02 | 19.1 |
Neuren Pharmaceuticals Ltd (ASX:NEU) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Neuren Pharmaceuticals Ltd
ISIN : NZNEUE0001S8
Description
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers